









Markets
/
Stocks
/
nasdaq-dmiiu
/

Drugs Made In America Acquisition II Units

DMIIU

10.020USD

0.000

Close 12/10, 16:00（ET）Quotes delayed by 15 min

657.06MMarket Cap

--P/E TTM



Drugs Made In America Acquisition II Units

10.020

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can find the annual or quarterly income statement of Drugs Made In America Acquisition II Units here for insights into the performance and operational efficiency of Drugs Made In America Acquisition II Units.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Operating expenses

--155.51K

Operating profit

---155.51K

Net non-operating interest income (expenses)

Non-operating interest income

--109.36K

Income before tax

---46.16K

Income after tax

---46.16K

Net income from continuous operations

---46.16K

Net income attributable to controlling interests

---46.16K

Net income attributable to common shareholders

---46.16K

Basic earnings per share

--0.00

Diluted earnings per share

--0.00

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

